Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.

Kim DY, Park E, Heo CY, Jin US, Kim EK, Han W, Shin KH, Kim IA

Open source

DOI
10.1016/j.breast.2020.11.020
Published
2021 Feb
Container
Breast (Edinburgh, Scotland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2020.11.020,
  title = {Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.},
  author = {Kim DY and Park E and Heo CY and Jin US and Kim EK and Han W and Shin KH and Kim IA},
  year = {2021},
  journal = {Breast (Edinburgh, Scotland)},
  doi = {10.1016/j.breast.2020.11.020},
  url = {https://doi.org/10.1016/j.breast.2020.11.020}
}

RIS

TY  - JOUR
TI  - Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.
AU  - Kim DY
AU  - Park E
AU  - Heo CY
AU  - Jin US
AU  - Kim EK
AU  - Han W
AU  - Shin KH
AU  - Kim IA
PY  - 2021
JO  - Breast (Edinburgh, Scotland)
DO  - 10.1016/j.breast.2020.11.020
UR  - https://doi.org/10.1016/j.breast.2020.11.020
ER  - 

APA

DY, K., E, P., CY, H., US, J., EK, K., W, H., KH, S., & IA, K. (2021). Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2020.11.020

Source records